Aller au contenu principal
Profil bibliographique

Aravinthan Vignarajah

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

112Publications signalées
56Citations signalées
6Affiliations récentes

Les institutions déclarées

Les domaines associés

Atrial Fibrillation Management and OutcomesDiabetes Treatment and ManagementCardiac pacing and defibrillation studiesHeart Failure Treatment and ManagementCardiac Arrhythmias and Treatments

Les publications récentes

Accès ouvert 2026 article OpenAlex

Lipoprotein(a) in Personalized Cardiovascular Prevention: Risk Stratification, Coronary Artery Calcium, and Emerging Lp(a)-Lowering Therapies

Alveena Batool Syed, Samuel Michalak, I Potulapati, Aravinthan Vignarajah et autres

Lipoprotein(a) [Lp(a)] is an independent and causal risk factor for atherosclerotic cardiovascular disease (ASCVD) and calcific aortic valve stenosis (CAVS), with plasma levels largely genetically determined and minimally influenced by lifestyle. Contemporary dyslipidemia guidelines now recommend at least one lifetime measurement and …

us (code pays fourni par la source)

0 citations Journal of Clinical Medicine
Accès ouvert 2026 article OpenAlex

Management of recurrent atrial fibrillation after catheter ablation: 5-year outcomes of repeat catheter ablation vs. antiarrhythmic therapy

Yong Hao Yeo, Helen Wong, Aravinthan Vignarajah, Min Choon Tan et autres

AIMS: Recurrence of symptomatic atrial fibrillation (AF) after catheter ablation (CA) is not uncommon. However, real-world long-term data on clinical outcomes of rhythm control strategies in patients with recurrent AF after CA remain limited. METHODS AND RESULTS: Using the TriNetX database, we …

us (code pays fourni par la source)

0 citations EP Europace
Accès ouvert 2026 article OpenAlex

Dynamic LVOT Obstruction After Mitral Valve Repair in HCM

El‐Moatasem Gabr, Aravinthan Vignarajah, Gautam Shah

BACKGROUND: Mitral valve repair (MVr) can alter left ventricular outflow tract (LVOT) geometry and precipitate dynamic LVOT obstruction (LVOTO) in patients with underlying hypertrophic cardiomyopathy (HCM). Cardiac myosin inhibitors are now a Class I recommendation for symptomatic obstructive HCM, yet their role …

us (code pays fourni par la source)

1 citation JACC Case Reports
2026 article OpenAlex

Real-world outcomes of cilta-cel versus BCMA-targeting bispecific antibodies in relapsed/refractory multiple myeloma

Jia Yi Tan, Aravinthan Vignarajah, Lay She Ng, Atiqah Nurliyanah et autres

Chimeric antigen receptor (CAR) T-cell therapy and bispecific antibodies (BsAbs) have emerged as transformative options for patients with relapsed or refractory multiple myeloma (RRMM). Both modali...

us, my (code pays fourni par la source)

0 citations Leukemia & lymphoma/Leukemia and lymphoma
2026 article OpenAlex

Outcomes of extended reduced‐dose apixaban versus full‐dose apixaban in cancer‐associated venous thromboembolism

Jia Yi Tan, Aravinthan Vignarajah, Yong Hao Yeo, Lay She Ng et autres

Venous thromboembolism (VTE) is one of the important causes of morbidity and mortality among patients with active malignancy. Current guidelines from the American Society of Clinical Oncology (ASCO) suggest extended anticoagulation for patients with active cancer and established VTE to prevent recurrent …

us (code pays fourni par la source)

0 citations British Journal of Haematology

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.